XML 106 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Cash Flows Statements (USD $)
In Millions, unless otherwise specified
12 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2011
Operations      
Net income $ 21,863 [1] $ 16,978 [2] $ 23,150
Adjustments to reconcile net income to net cash from operations:      
Goodwill impairment 0 6,193 0
Depreciation, amortization, and other 3,755 2,967 2,766
Stock-based compensation expense 2,406 2,244 2,166
Net recognized losses (gains) on investments and derivatives 80 (200) (362)
Excess tax benefits from stock-based compensation (209) (93) (17)
Deferred income taxes (19) 954 2
Deferral of unearned revenue 44,253 36,104 31,227
Recognition of unearned revenue (41,921) (33,347) (28,935)
Changes in operating assets and liabilities:      
Accounts receivable (1,807) (1,156) (1,451)
Inventories (802) 184 (561)
Other current assets (129) 493 (1,259)
Other long-term assets (478) (248) 62
Accounts payable 537 (31) 58
Other current liabilities 146 410 (1,146)
Other long-term liabilities 1,158 174 1,294
Net cash from operations 28,833 31,626 26,994
Financing      
Short-term debt repayments, maturities of 90 days or less, net 0 0 (186)
Proceeds from issuance of debt 4,883 0 6,960
Repayments of debt (1,346) 0 (814)
Common stock issued 931 1,913 2,422
Common stock repurchased (5,360) (5,029) (11,555)
Common stock cash dividends paid (7,455) (6,385) (5,180)
Excess tax benefits from stock-based compensation 209 93 17
Other (10) 0 (40)
Net cash used in financing (8,148) (9,408) (8,376)
Investing      
Additions to property and equipment (4,257) (2,305) (2,355)
Acquisition of companies, net of cash acquired, and purchases of intangible and other assets (1,584) (10,112) (71)
Purchases of investments (75,396) (57,250) (35,993)
Maturities of investments 5,130 15,575 6,897
Sales of investments 52,464 29,700 15,880
Securities lending payable (168) (394) 1,026
Net cash used in investing (23,811) (24,786) (14,616)
Effect of exchange rates on cash and cash equivalents (8) (104) 103
Net change in cash and cash equivalents (3,134) (2,672) 4,105
Cash and cash equivalents, beginning of period 6,938 9,610 5,505
Cash and cash equivalents, end of period $ 3,804 $ 6,938 $ 9,610
[1] Includes a charge related to a fine imposed by the European Commission in March 2013 which decreased net income by $733 million (€561 million) and diluted earnings per share by $0.09. Also includes a charge for Surface RT inventory adjustments recorded in the fourth quarter of fiscal year 2013, which decreased net income by $596 million and diluted earnings per share by $0.07.
[2] Includes a goodwill impairment charge related to our previous OSD business segment (related to Devices and Consumer Other under our current segment structure) which decreased net income by $6.2 billion and diluted earnings per share by $0.73.